HCA Healthcare (NYSE:HCA) Price Target Cut to $440.00

HCA Healthcare (NYSE:HCA) had its target price reduced by TD Cowen from $450.00 to $440.00 in a research note issued on Monday, Benzinga reports. The firm presently has a “buy” rating on the stock. TD Cowen’s price target points to a potential upside of 22.01% from the stock’s current price.

Other analysts also recently issued research reports about the stock. StockNews.com raised shares of HCA Healthcare from a “buy” rating to a “strong-buy” rating in a report on Monday, July 1st. KeyCorp dropped their price objective on HCA Healthcare from $475.00 to $420.00 and set an “overweight” rating for the company in a research report on Monday. Wolfe Research raised shares of HCA Healthcare to a “strong-buy” rating in a report on Thursday, August 29th. Royal Bank of Canada raised their price target on shares of HCA Healthcare from $378.00 to $405.00 and gave the stock an “outperform” rating in a report on Friday, August 23rd. Finally, Barclays raised their price objective on shares of HCA Healthcare from $376.00 to $396.00 and gave the stock an “overweight” rating in a research report on Wednesday, July 24th. Five research analysts have rated the stock with a hold rating, thirteen have given a buy rating and three have assigned a strong buy rating to the company’s stock. According to MarketBeat, HCA Healthcare currently has an average rating of “Moderate Buy” and an average price target of $379.11.

HCA Healthcare Price Performance

NYSE:HCA traded down $2.91 during trading hours on Monday, reaching $360.64. 647,935 shares of the company were exchanged, compared to its average volume of 1,155,092. HCA Healthcare has a 1-year low of $222.23 and a 1-year high of $417.14. The business has a 50 day moving average of $395.06 and a 200 day moving average of $352.71. The company has a debt-to-equity ratio of 27.11, a current ratio of 1.06 and a quick ratio of 0.94. The company has a market capitalization of $94.46 billion, a P/E ratio of 17.97, a P/E/G ratio of 1.52 and a beta of 1.67.

Insider Activity

In other HCA Healthcare news, SVP Kathleen M. Whalen sold 2,987 shares of the firm’s stock in a transaction on Wednesday, July 31st. The shares were sold at an average price of $363.51, for a total value of $1,085,804.37. Following the completion of the transaction, the senior vice president now directly owns 9,454 shares of the company’s stock, valued at $3,436,623.54. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. In related news, EVP Michael S. Cuffe sold 8,358 shares of the company’s stock in a transaction on Thursday, September 12th. The shares were sold at an average price of $385.42, for a total value of $3,221,340.36. Following the completion of the transaction, the executive vice president now directly owns 29,678 shares in the company, valued at approximately $11,438,494.76. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, SVP Kathleen M. Whalen sold 2,987 shares of the company’s stock in a transaction dated Wednesday, July 31st. The stock was sold at an average price of $363.51, for a total value of $1,085,804.37. Following the completion of the transaction, the senior vice president now owns 9,454 shares of the company’s stock, valued at $3,436,623.54. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.60% of the stock is owned by company insiders.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently bought and sold shares of HCA. NorthRock Partners LLC lifted its position in HCA Healthcare by 17.4% in the first quarter. NorthRock Partners LLC now owns 1,310 shares of the company’s stock valued at $437,000 after purchasing an additional 194 shares during the last quarter. MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH increased its stake in shares of HCA Healthcare by 2,471.9% during the first quarter. MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH now owns 7,690 shares of the company’s stock valued at $2,565,000 after buying an additional 7,391 shares during the period. Hedeker Wealth LLC increased its position in shares of HCA Healthcare by 0.8% during the first quarter. Hedeker Wealth LLC now owns 11,117 shares of the company’s stock valued at $3,708,000 after buying an additional 89 shares during the period. Carret Asset Management LLC boosted its position in HCA Healthcare by 1.9% during the 1st quarter. Carret Asset Management LLC now owns 10,095 shares of the company’s stock valued at $3,367,000 after acquiring an additional 190 shares in the last quarter. Finally, Denali Advisors LLC lifted its stake in shares of HCA Healthcare by 14.3% in the 1st quarter. Denali Advisors LLC now owns 2,400 shares of the company’s stock valued at $800,000 after purchasing an additional 300 shares during the period. 62.73% of the stock is currently owned by institutional investors.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.